Lacunar infarcts;Lakunäre infarkte

Therapeutische Umschau

Volumn 60, Issue 9, 2003, Pages 535-540

  Norrving, Bo ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

AGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; COMORBIDITY; DEATH; DEMENTIA; HUMAN; HYPERTENSION; OCCLUSIVE CEREBROVASCULAR DISEASE; PROGNOSIS; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; WHITE MATTER;

EID: 0141515793     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.60.9.535     Document Type: Review

References (20)

1. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-6.
2. Petty, G-W, Brown Jr RD, Whisnant JP, Sicks J.D, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study on incidence and risk factors. Stroke 1999; 30: 2513-6.
3. nd edn. Cambridge, Cambridge University Press, 2000: 583-9.
4. Metz RJ, Bogousslavsky J. Lacunar stroke. In Fisher M, Bogousslavsky J, eds: Current Review of Cerebrovascular Disease. 4th edn. Philadelphia, Current Medicine Inc, 2001: 115-22.
5. nd edn. Oxford, Oxford Medical Publications, 2002: 27-34.
6. Fisher CM. Lacunar infarcts-a review. Cerebrovascalar Diseases 1991; 1, 311-20.
7. Lammie GA. Pathology of small vessel stroke. British Medical Bulletin 2000; 56: 296-306.
8. Toni D, Iweins F, von Kummer R, Busse O, Bogousslavsky J, Falcou A, et al. Identification of lacunar infarcts before thrombolysis in the ECASS I study. Neurology 2000; 54: 684-8.
9. Ay H, Oliviera-Filho J, Buonanno FS, Ezzeddine M, Schaefer PW, Rordorf G, Schwamm LH, Gonzales RG, Koroshetz WJ. Diffusion-weighted imaging identifies a subset of lacunar infarction associated with embolic source. Stroke 1999; 30: 2644-50.
10. Gan R, Sacco RL, Kargman DE, Roberts JK, Boden-Albala B, Gu Q. Testing the validity of the lacunar hypothesis: the Northern Manhattan Stroke Study experience. Neurology 1997; 48: 1204-11.
11. Staaf G, Lindgren A, Norrving B. Lacunar infarcts: a 10-year follow-up study. Stroke 2001; 32: 2592-6.
12. Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurology 2003; 2: 238-45.
13. De Jong G, Kessels F, Lodder J. Two types of lacunar infarcts. Further arguments from a study on prognosis. Stroke 2002; 33: 2072-6.
14. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurologly 2002; 1: 426-36.
15. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T et al. Vacular cognitive impairment. Lancet Neurology 2003; 2: 89-98.
16. Vermeer S, Prins ND, den Heijner T, Hofman, Koudstaal PJ, Breteler MMB. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-22.
17. Van Zagten M, Boiten J, Kessels F, Lodder J. Significant progression of white matter lesions and small deep (lacunar) infarcts in patients with stroke. Archives of Neurology 1996; 53: 650-5.
18. nd edn. Oxford, Oxford Medical Publications, 2002: 313-33.
19. PROGRESS Collaborative Group. Randomised trial of perindopril-baseod blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2001; 358: 1033-41.
20. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-21.